LAURA MULLER: Open Payments
NPI 1295505568 · PORT CLINTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,103 in 85 payments from 36 companies in 2025. Trend: 2023 $0 · 2024 $1,772 · 2025 $2,103
Food & beverage: $2,023Education: $80
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $411 |
| AstraZeneca Pharmaceuticals LP | 8 | $181 |
| Janssen Biotech, Inc. | 6 | $163 |
| Eisai Inc. | 4 | $105 |
| Daiichi Sankyo Inc. | 2 | $102 |
| Incyte Corporation | 4 | $77 |
| Exelixis Inc. | 2 | $75 |
| Celgene Corporation | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
Products named: KEYTRUDA, RYBREVANT, Lenvima, IMFINZI, PADCEV, CABOMETYX, REBLOZYL, OPDIVO.
Industry payments across OH — which companies pay providers there.
